KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...
MarketWatch15d
Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal
Separately, Henry Schein named a new independent director, Robert Hombach. Hombach formerly served as chief operations officer and chief financial officer of biopharmaceutical firm Baxalta.
Morningstar16d
Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
Henry Schein, Inc. (Nasdaq ... Separately, the Board has appointed Robert J. “Bob” Hombach as an independent director. Mr. Hombach, former Executive Vice President, Chief Financial Officer ...
Henry Schein announces $250M strategic investment by KKR, board changes
Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current ...
Seeking Alpha15d
Henry Schein announces KKR investment, prelim. Q4 sales (update)
Henry Schein (NASDAQ:HSIC ... collaborate with the New York firm to improve shareholder value. Additionally, Robert J. “Bob” Hombach, a former CFO of Baxter (BAX), is also expected to join ...
AOL15d
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Additionally, the Board has appointed Robert Hombach as an independent director. In addition, Henry Schein’s Board has authorized an increase of $500 million to its share repurchase program ...